Mode
Text Size
Log in / Sign up
N/A N=53 Randomized Single-blind Treatment

Xylitol Versus Saline in Chronic Sinusitis

Chronic Sinusitis

Enrolled (actual)
53
Serious AEs
0.0%
Results posted
Aug 2017
Primary outcome: Primary: SNOT-20 Scores at 12 Weeks — 7; 11 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Xylitol (Drug); Saline (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Iowa
Primary completion
Aug 2014

Outcome Measures

OutcomeResultp-value
PRIMARY
SNOT-20 Scores at 12 Weeks
7; 11
SECONDARY
Mean Number of Antibiotic Courses During the Study Period
1.90; 1.77

Summary

Is a xylitol nasal rinse better or worse than saline on patient satisfaction.

Eligibility Criteria

We now have two arms to this study.

Group I: Immunocompetent subjects with chronic rhinosinusitis

Inclusion Criteria

  • 56 Adult subjects (18 or older) presenting to the ENT(ears, nose, throat) clinics who meet the diagnosis of chronic rhinosinusitis (CRS). Definition of CRS: Presence of at least 2 of the following 4 signs/symptoms for 12 weeks or longer despite medical management:
  • Anterior and/or posterior mucopurulent drainage
  • Nasal obstruction
  • Facial pain, pressure, and/or fullness
  • Decreased sense of smell
  • In addition, objective evidence of sinus mucosal disease must be demonstrated on sinus CT imaging or direct endoscopic examination.

Exclusion Criteria

  • Cystic fibrosis
  • Fungal sinusitis
  • Immunocompromised status (use of long term oral steroids (> 30 days), AIDS, active malignancy or chemotherapy)
  • Known Ciliary disorders
  • Sinonasal tumors
  • Pregnancy

Group 2: CRS with antibody deficiency

  • 56 Adult subjects (18 or older) presenting to the Allergy clinic who meet the diagnosis of chronic rhinosinusitis (CRS). Definition of CRS: Presence of at least 2 of the following 4 signs/symptoms for 12 weeks or longer despite medical management:
  • Anterior and/or posterior mucopurulent drainage
  • Nasal obstruction
  • Facial pain, pressure, and/or fullness
  • Decreased sense of smell
  • In addition, objective evidence of sinus mucosal disease must be demonstrated on sinus CT imaging or direct endoscopic examination.

Exclusion criteria

Cystic Fibrosis Sinonasal tumors Pregnancy

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00924404). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search